NICE guideline review: Epilepsies in children, young people and adults NG217

• Published in: Archives of disease in childhood. Education and practice edition Vol. 108; no. 6; pp. 416 - 421
• Main Authors: Jones, Katherine Elizabeth Anne, Howells, Rachel, Mallick, Andrew A, Paul, Siba Prosad, Dey, Indranil
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01.12.2023; BMJ Publishing Group LTD
• Subjects: Anesthesia; Cannabidiol; Children; Children & youth; Convulsions & seizures; Electroencephalography; Emergency Care; Epilepsy; Genetic testing; Girls; Guideline review; Health care; Neurology; Neurosurgery; Paediatric Emergency Medicine; Paediatrics; Pediatrics; Sodium; United Kingdom > UK; Paediatric Emergency Medicine; Neurology; Emergency Care; Neurosurgery; Paediatrics
• ISSN: 1743-0585; 1743-0593
• DOI: 10.1136/archdischild-2022-324427

Correspondence to Dr Katherine Elizabeth Anne Jones, Department of Paediatrics, Royal Devon University Healthcare NHS Foundation Trust, Exeter, EX2 5DW, UK; katherinejones3@nhs.net Background Epilepsy is the most common significant long-term neurological condition of childhood. The International League against Epilepsy is more specific, defining epilepsy as a disease of the brain defined by at least two unprovoked seizures occurring more than 24 hours apart, one unprovoked seizure and a high probability of further seizures or a diagnosis of an epilepsy syndrome.2 Information about the current guideline In April 2022, NICE published updated guidelines for the diagnosis and management of epilepsies in children, young people and adults (NG217), aiming to improve diagnosis and treatment and reduce the risks for people with epilepsy. Vagus nerve stimulation for refractory epilepsy in children: https://www.nice.org.uk/guidance/ipg50. Avoid prescribing sodium valproate to girls of childbearing potential as per the Medicines and Healthcare Products Regulatory Authority (MHRA) advice.